# Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition

> **NCT01166100** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 54 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Fluoxetine Hydrochloride

## Key facts

- **NCT ID:** NCT01166100
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2006-03
- **Final completion:** 2006-08
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2010-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01166100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01166100, "Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01166100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*